PATENT CLAIM ANALYSIS

Application Number: 16324985
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "178000"]

Abstract:
A class of cyanosteroid compounds that efficiently inhibit ghrelin acylation by ghrelin O-acyltransferase. The compounds have a steroid scaffold with α,β-unsaturated ketone in the A ring position such an α-cyanoenone. Exemplary compounds include (5S,8S,9S,10S,13S,14S)-10,13-dimethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthrene-2-carbonitrile.

Claim (Index 1):
A human ghrelin O-acyltransferase inhibitor, comprising a steroid scaffold having \u03b1,\u03b2-unsaturated ketone in an A ring position.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13699611', '14801218', '14421818', '12149336', '13391148']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7401718484263942
- 35 USC 102 Novelty (BERT): 0.5024483937103609
- Combined Prediction Score: 0.7163995029547908
- Mean Citation Score: 213.67119
- Max Citation Score: 216.05742
- Similarity Product: 134.10161248642444

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test